富爾金特遺傳學公司
MX ˙ BMV ˙ US3596641098
SecurityMX:FLGT / Fulgent Genetics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership240,759 shares
Latest Disclosed Value $ 3,828,068
UBS Group AG reports 188.13% increase in ownership of FLGT / Fulgent Genetics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 240,759 shares of Fulgent Genetics, Inc. (MX:FLGT) valued at $3,828,068 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 83,559 shares of Fulgent Genetics, Inc.. This represents a change in shares of 188.13% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F FULGENT GENETICS COM 359664109 240,759 157,200 188.13 3,828 74.40 0.0001
2026-01-29 2025-12-31 13F FULGENT GENETICS COM 359664109 83,559 62,070 288.85 2,195 352.58 0.0004
2025-11-13 2025-09-30 13F FULGENT GENETICS COM 359664109 21,489 -54,734 -71.81 486 -67.99 0.0001
2025-08-14 2025-06-30 13F FULGENT GENETICS COM 359664109 76,223 57,651 310.42 1,515 384.03 0.0003
2025-05-13 2025-03-31 13F FULGENT GENETICS COM 359664109 18,572 -33,988 -64.67 314 -67.73 0.0001
2025-02-14 2024-12-31 13F FULGENT GENETICS COM 359664109 52,560 42,648 430.27 971 351.16 0.0002
2024-11-14 2024-09-30 13F FULGENT GENETICS COM 359664109 9,912 -10,466 -51.36 215 -46.12 0.0000
2024-08-14 2024-06-30 13F FULGENT GENETICS COM 359664109 20,378 -6,752 -24.89 400 -32.14 0.0001
2024-05-13 2024-03-31 13F FULGENT GENETICS COM 359664109 27,130 -3,737 -12.11 589 -34.08 0.0001
2024-02-09 2023-12-31 13F FULGENT GENETICS COM 359664109 30,867 15,028 94.88 892 110.87 0.0003
2023-11-09 2023-09-30 13F FULGENT GENETICS COM 359664109 15,839 2,448 18.28 424 -14.55 0.0001
2023-08-11 2023-06-30 13F FULGENT GENETICS COM 359664109 13,391 2,552 23.54 496 46.45 0.0002
2023-05-12 2023-03-31 13F FULGENT GENETICS COM 359664109 10,839 -1,623 -13.02 338 -8.89 0.0001
2023-02-08 2022-12-31 13F FULGENT GENETICS COM 359664109 12,462 -709 -5.38 371 -26.24 0.0001
2022-11-10 2022-09-30 13F FULGENT GENETICS COM 359664109 13,171 -7,859 -37.37 503 -56.15 0.0002
2022-08-10 2022-06-30 13F FULGENT GENETICS COM 359664109 21,030 -10,507 -33.32 1,147 -41.72 0.0005
2022-05-16 2022-03-31 13F FULGENT GENETICS COM 359664109 31,537 -14,978 -32.20 1,968 -57.94 0.0007
2022-02-14 2021-12-31 13F FULGENT GENETICS COM 359664109 46,515 5,592 13.66 4,679 27.11 0.0013
2021-11-15 2021-09-30 13F FULGENT GENETICS COM 359664109 40,923 11,880 40.90 3,681 37.40 0.0012
2021-08-13 2021-06-30 13F FULGENT GENETICS COM 359664109 29,043 632 2.22 2,679 -2.40 0.0009
2021-05-12 2021-03-31 13F FULGENT GENETICS COM 359664109 28,411 961 3.50 2,745 91.96 0.0009
2021-02-11 2020-12-31 13F FULGENT GENETICS COM 359664109 27,450 26,830 4,327.42 1,430 5,620.00 0.0005
2020-11-12 2020-09-30 13F FULGENT GENETICS COM 359664109 620 -3,381 -84.50 25 -60.94 0.0000
2020-07-31 2020-06-30 13F FULGENT GENETICS COM 359664109 4,001 3,188 392.13 64 611.11 0.0000
2020-05-01 2020-03-31 13F FULGENT GENETICS COM 359664109 813 -650 -44.43 9 -52.63 0.0000
2020-02-14 2019-12-31 13F FULGENT GENETICS COM 359664109 1,463 138 10.42 19 35.71 0.0000
2019-11-14 2019-09-30 13F FULGENT GENETICS COM 359664109 1,325 1,325 14 0.0000
2019-02-14 2018-12-31 13F FULGENT GENETICS COM 359664109 0 -1,189 -100.00 0 -100.00
2018-11-14 2018-09-30 13F FULGENT GENETICS COM 359664109 1,189 -630 -34.63 5 -37.50 0.0000
2018-08-14 2018-06-30 13F FULGENT GENETICS COM 359664109 1,819 12 0.66 8 14.29 0.0000
2018-05-15 2018-03-31 13F FULGENT GENETICS COM 359664109 1,807 1,407 351.75 7 250.00 0.0000
2018-02-14 2017-12-31 13F FULGENT GENETICS COM 359664109 400 -1,345 -77.08 2 -75.00 0.0000
2017-11-14 2017-09-30 13F FULGENT GENETICS COM 359664109 1,745 1,703 4,054.76 8 0.0000
2017-11-14 2017-06-30 13F/A-1 FULGENT GENETICS COM 359664109 42 -353 -89.37 0 -100.00
2017-08-14 2017-06-30 13F FULGENT GENETICS COM 359664109 42 -353 0
2017-11-14 2017-03-31 13F/A-1 FULGENT GENETICS COM 359664109 395 -741 -65.23 4 -69.23 0.0000
2017-05-12 2017-03-31 13F FULGENT GENETICS COM 359664109 395 -741 4
2017-02-14 2016-12-31 13F FULGENT GENETICS COM 359664109 1,136 1,136 13 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.